The U.S. Food and Drug Administration (FDA) partnered with other agencies, created the Coronavirus Treatment Acceleration Program (CTAP) and used every available procedural tool, including the Emergency Use Authorization (EUA), to aggressively respond to the realities of COVID-19. Understand the impact of these actions and what they mean for the future. Read the full article written by Coda Corp USA.
Enjoying this blog? Learn more.
The Ultimate Guide to Connected Quality DataGet the Guide